Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (45)

2024

  1. Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 711-723

2023

  1. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

2022

  1. Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 27, pp. 3151-3161

2021

  1. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia

    Blood, Vol. 137, Núm. 14, pp. 1879-1894

2020

  1. A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial

    Cancer Medicine, Vol. 9, Núm. 7, pp. 2317-2329

  2. Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma

    Blood, Vol. 136, Núm. 2, pp. 199-209

  3. Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 38, Núm. 8, pp. 784-792

2019

  1. Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials

    European Journal of Haematology, Vol. 102, Núm. 1, pp. 79-86

2018

  1. Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia

    Leukemia and Lymphoma, Vol. 59, Núm. 7, pp. 1634-1643

2016

  1. Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes

    F1000Research, Vol. 5

2015

  1. Critical analysis of the stringent complete response in multiple myeloma: Contribution of sFLC and bone marrow clonality

    Blood, Vol. 126, Núm. 7, pp. 858-862

2012

  1. A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors

    EMBO Journal, Vol. 31, Núm. 18, pp. 3704-3717

  2. Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 67, Núm. 6, pp. 813-821

2011

  1. Comparison of immunofixation, serum free light chain, and immunophenotyping for response evaluation and prognostication in multiple myeloma

    Journal of Clinical Oncology, Vol. 29, Núm. 12, pp. 1627-1633

  2. Dermoscopic features of skin lesions in patients with mastocytosis

    Archives of Dermatology, Vol. 147, Núm. 8, pp. 932-940

  3. Evaluation of basophil activation in mastocytosis with hymenoptera venom anaphylaxis

    Cytometry Part B - Clinical Cytometry, Vol. 80 B, Núm. 3, pp. 167-175

2010

  1. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms

    Journal of Allergy and Clinical Immunology, Vol. 125, Núm. 6

  2. Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes

    Journal of Allergy and Clinical Immunology, Vol. 125, Núm. 3

2009

  1. Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients

    Journal of Allergy and Clinical Immunology, Vol. 124, Núm. 3, pp. 514-521

2008

  1. CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linking

    International Journal of Immunopathology and Pharmacology, Vol. 21, Núm. 4, pp. 797-806